Wolfe Research analyst Steven Chubak downgrades Cowen (NASDAQ:COWN) from Outperform to Peer Perform.
Immunogen Q3 EPS $(0.31) Misses $(0.25) Estimate, Sales $15.38M Beat $12.48M Estimate
Immunogen (NASDAQ:IMGN) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.25) by 24 percent. This is a 72.22 percent decrease over losses of $(0.18) per share from the same
